Daclatasvir Dihydrochloride and Fiasp
Determining the interaction of Daclatasvir Dihydrochloride and Fiasp and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Fiasp Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Fiasp (Insulin Aspart (Cartridges & Prefilled Pens) (Fiasp))
- Daclatasvir Dihydrochloride-Fiasp (Insulin Aspart (Vials) (Fiasp))
- Daclatasvir Dihydrochloride-Fiasp (Insulin Aspart (Vials))
- Daclatasvir Dihydrochloride-Fiasp FlexTouch
- Daclatasvir Dihydrochloride-Fiasp Injection
- Daclatasvir Dihydrochloride-Fiber Lax
- Fiasp-Daclizumab
- Fiasp-Daclizumab Subcutaneous
- Fiasp-Dacogen
- Fiasp-Dacomitinib
- Fiasp-Dactinomycin
- Fiasp-Dactinomycin Injection